RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE

Enzo Biochem Stocks 2024

Enzo Biochem Stocks

49.16 M

Enzo Biochem Dividend yield

Ticker

ENZ

ISIN

US2941001024

WKN

865607

In 2024, Enzo Biochem had 49.16 M outstanding stocks, a 1.16% change from the 48.59 M stocks in the previous year.

The Enzo Biochem Stocks history

YEARNUMBER OF STOCKS (undefined USD)
202349.16
202248.59
202148.33
202047.7
201947.5
201847
201746.4
201646.6
201545.4
201442.6
201339.6
201238.8
201138.4
201038
200937.5
200836.9
200735
200632.2
200532.8
200431.7

Enzo Biochem Aktienanalyse

What does Enzo Biochem do?

Enzo Biochem Inc is a US-based company operating in the biotechnology sector. It was founded in 1976 by Elazar Rabbani and is headquartered in New York. The company focuses on developing, producing, and marketing innovative diagnostic and therapeutic products for the medical industry. Enzo Biochem Inc's business model is based on the application of modern technologies for the development and synthesis of molecules for medical technology and life sciences. At the same time, the company also offers diagnostic testing systems and clinical laboratory services to its customers. Enzo Biochem's business model is therefore diverse and covers various areas. Enzo Biochem divides its business into three main segments: life sciences, clinical labs, and therapeutics. In the life sciences segment, the company engages in research and development of technologies for synthesizing molecules for medical technology. In the clinical labs segment, Enzo Biochem offers diagnostic testing systems and clinical laboratory services for use in medical diagnostics. The therapeutics segment manufactures therapeutic products for the treatment of viral infections. Enzo Biochem's product offering includes a wide range of products and services. This includes molecules for medical technology, diagnostic testing systems, and therapy products for viral infections. The product lines of Enzo Biochem include: - Molecules for medical technology: Enzo Biochem has developed a wide range of molecules for medical technology and is a leader in this field. These molecules include proteins, antibodies, and other biomolecules. The company also offers custom molecules for specific applications. - Diagnostic testing systems: The company offers a wide range of diagnostic testing systems tailored to the needs of laboratories and clinics. The tests include tests for infectious diseases, cancer, metabolic disorders, and other diseases. - Clinical laboratory services: Enzo Biochem provides a wide range of clinical laboratory services, including blood tests, microbiological tests, urine, stool, and body fluid tests, as well as histological analysis of tissue samples. - Therapy products: Enzo Biochem has developed a broad portfolio of therapy products for the treatment of viral infections. These products include immunomodulators, antivirals, and other therapeutics aimed at combating various pathogens. Enzo Biochem has made a name for itself in the biotechnology industry through continuous innovation and high-quality products. The company has also engaged in partnerships, acquisitions, and joint ventures to expand its global footprint. It has a global presence and works with leading pharmaceutical and biotech companies from around the world. Overall, Enzo Biochem has established itself as a leading biotechnology company operating in the fields of life sciences, clinical labs, and therapeutics. The company offers a wide range of products and services tailored to the needs of laboratories and clinics. Enzo Biochem has established itself as an innovation leader in the biotechnology industry and is committed to further expanding its business through the development of new products and technologies. Enzo Biochem ist eines der beliebtesten Unternehmen auf Eulerpool.com.

Stocks Details

Evaluating Enzo Biochem's Shares Outstanding

Enzo Biochem's shares outstanding refer to the total number of shares that are currently held by all its shareholders, including institutional investors and restricted shares held by the company’s officers and insiders. The number of shares outstanding is crucial in determining the company's market capitalization and is used by investors to assess the company’s size, financial health, and investment potential.

Year-to-Year Comparison

Tracking the changes in Enzo Biochem’s shares outstanding over the years can provide investors with insights into the company's financial strategies and market valuation. An increase in shares outstanding can result from actions like issuing new shares, while a decrease can result from buybacks.

Impact on Investments

For investors, understanding Enzo Biochem’s shares outstanding is essential for evaluating its earnings per share (EPS) and market valuation. A change in the number of shares outstanding can impact the EPS, which is a significant driver of stock prices and investor decisions.

Interpreting Changes in Shares Outstanding

Variances in Enzo Biochem’s shares outstanding can signal shifts in the company’s financial strategy. An increase may dilute the EPS and share value, indicating potential fundraising or acquisitions. Conversely, a decrease, often due to share buybacks, can enhance share value and indicate the company’s confidence in its financial performance.

Frequently Asked Questions about Enzo Biochem Stock

How many stocks are there of Enzo Biochem?

The current number of stocks of Enzo Biochem is 49.16 M undefined.

What does Number of Shares / OutstandingShares mean?

The outstanding shares (or issued shares) of Enzo Biochem are the total number of shares issued and actively held by shareholders - both external investors and company insiders. However, these must be actual shares. may grant stock options to executives that can be converted into shares.

How has the number of shares of Enzo Biochem evolved in recent years?

The number of shares of Enzo Biochem has increased by 1.16% gestiegen compared to last year.

What does the number of shares mean for investors?

The number of shares outstanding is used to calculate key metrics such as a company's market capitalization, earnings per share (EPS), and cash flow per share (CFPS). The number of outstanding shares of a company is not static and can fluctuate greatly over time.

Why does the number of stocks fluctuate?

There are various factors that can lead to a change. Enzo Biochem as a company can issue new shares, carry out stock splits or reverse splits.

Does the number of shares have an impact on the performance of Enzo Biochem?

There is no tangible long-term evidence or study that stocks with a certain number of shares (regardless of Mega/Large/Mid/Small Cap) would yield significantly higher returns than others. There are occasional small studies (limited number of stocks, short investment period) that certain classes outperform or have higher risk, but none of them are 1. conclusive (cause-effect is unclear, experiment is not repeatable) or 2. generalizable (generalization is not possible due to small sample size and time period).

How much dividend does Enzo Biochem pay?

Over the past 12 months, Enzo Biochem paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Enzo Biochem is expected to pay a dividend of 0 USD.

What is the dividend yield of Enzo Biochem?

The current dividend yield of Enzo Biochem is .

When does Enzo Biochem pay dividends?

Enzo Biochem pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of Enzo Biochem?

Enzo Biochem paid dividends every year for the past 0 years.

What is the dividend of Enzo Biochem?

For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.

In which sector is Enzo Biochem located?

Enzo Biochem is assigned to the 'Health' sector.

Wann musste ich die Aktien von Enzo Biochem kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Enzo Biochem from 4/27/2024 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 4/27/2024.

When did Enzo Biochem pay the last dividend?

The last dividend was paid out on 4/27/2024.

What was the dividend of Enzo Biochem in the year 2023?

In the year 2023, Enzo Biochem distributed 0 USD as dividends.

In which currency does Enzo Biochem pay out the dividend?

The dividends of Enzo Biochem are distributed in USD.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

The Enzo Biochem stock can be added to a savings plan with the following providers: Trade Republic

Andere Kennzahlen von Enzo Biochem

Our stock analysis for Enzo Biochem Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Enzo Biochem Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.